# Effect of Some Drugs on Rheumatoid Arithritis Activity

> **NCT03770923** · PHASE3 · RECRUITING · sponsor: **Sherief Abd-Elsalam** · enrollment: 75 (estimated)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Rupatadine
- **DRUG:** Montelukast

## Key facts

- **NCT ID:** NCT03770923
- **Lead sponsor:** Sherief Abd-Elsalam
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-10-01
- **Primary completion:** 2026-10
- **Final completion:** 2027-10
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2018-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03770923

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03770923, "Effect of Some Drugs on Rheumatoid Arithritis Activity". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT03770923. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*